Issues related to funding for newborn screenings for metachromatic leukodystrophy
2025 · 3rd Quarter (July 1 - Sep 30)
ORCHARD THERAPEUTICS NORTH AMERICA
Filed by S-3 GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- S-3 GROUP
- Filing UUID
- 73621ca5-89e0-485a-86af-3522d7ebb98d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.